SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-018327
Filing Date
2021-04-09
Accepted
2021-04-09 16:05:24
Documents
6
Period of Report
2021-05-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A eq-def14a_20210526.htm DEF 14A 702633
2 GRAPHIC gzwm4wk2zkql000002.jpg GRAPHIC 3725
3 GRAPHIC gzwm4wk2zkql000005.jpg GRAPHIC 46694
4 GRAPHIC gzwm4wk2zkql000003.jpg GRAPHIC 2865
5 GRAPHIC gzwm4wk2zkql000001.jpg GRAPHIC 18231
6 GRAPHIC gzwm4wk2zkql000004.jpg GRAPHIC 67307
  Complete submission text file 0001564590-21-018327.txt   895595
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

IRS No.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38692 | Film No.: 21817852
SIC: 2834 Pharmaceutical Preparations